Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharides
Marissa L. Maciej-Hulme,Jandi Kim,Elijah T. Roberts,Yiqing Zhang,Anouk van der Velden,Dirk den Braanker,Cansu Yanginlar,Mark de Graaf,Ton Rabelink,Bernard van den Berg,Ellen van Omen,Rutger Maas,Anne-Els van de Logt,I. Jonathan Amster,Johan van der Vlag
DOI: https://doi.org/10.1101/2024.09.18.613784
2024-09-19
Abstract:Heparan sulfates (HS) are a group of heterogenous linear, sulfated polysaccharides that play a role in in health and many diseases including cancer, cardiovascular, and kidney diseases. The structural variety of HS has greatly challenged the development and utility of HS analytics, particularly for native structures, leaving a significant gap in HS technologies for clinical application. Mass spectrometry (MS)-based profiling with bioinformatics offers a top-down approach that can retain variety in large data sets. Using healthy human plasmas, we developed an MS glycoprofiling approach for native HS oligosaccharides, which retains the structural complexity of each individual HS chain and generates an HS ‘index’ (or Heparan-ome) for each patient. As a proof of concept, analysis of 56 plasma samples ranging from 6 groups of kidney disease patients revealed a new subset cluster (20%, 4/20) of membranous glomerulopathy (MG) patients with distinct HS profiles, highlighting the potential of HS glycoprofiling as a powerful new approach into clinical practice, which warrants future development into clinical diagnostics of kidney and other diseases.
Bioinformatics